School of Medicine
Showing 3,401-3,420 of 13,034 Results
-
Uta Francke
Professor of Genetics and of Pediatrics, Emerita
Current Research and Scholarly InterestsFunctional consequences and pathogenetic mechanisms of mutations and microdeletions in human neurogenetic syndromes and mouse models. Integration of genomic information into medical care.
-
Aaron Frank
Affiliate, Department Funds
Resident in MedicineBioAaron Frank, MD is an Internal Medicine Resident Physician at Stanford Healthcare. He graduated with distinction in medical education innovation and was inducted into the AOA Medical Honor Society at UC Irvine School of Medicine. A prior television producer who worked with CNN, ABC, History, Discovery, HGTV, Food Network, Travel Channel, NBC, Vice, he is committed to innovate groundbreaking ways of incorporating new technology into medical education. He also is a co-executive director and co-Founder of Sewing For Lives, a 501(c)(3) nonprofit organization, and led a group of 2,500 worldwide volunteers in making over 250,000 masks for healthcare workers, police and fire departments, teachers, and students throughout the COVID-19 pandemic. At UC Irvine, he created over 50 physical exam instructional videos viewed by medical students and residents. In addition, he is a member of The Empathy Project at NYU with Jon LaPook, MD, Chief Medical Correspondent for CBS news.
-
Curtis Frank
W. M. Keck, Sr. Professor in Engineering, Emeritus
BioThe properties of ultrathin polymer films are often different from their bulk counterparts. We use spin casting, Langmuir-Blodgett deposition, and surface grafting to fabricate ultrathin films in the range of 100 to 1000 Angstroms thick. Macromolecular amphiphiles are examined at the air-water interface by surface pressure, Brewster angle microscopy, and interfacial shear measurements and on solid substrates by atomic force microscopy, FTIR, and ellipsometry. A vapor-deposition-polymerization process has been developed for covalent grafting of poly(amino acids) from solid substrates. FTIR measurements permit study of secondary structures (right and left-handed alpha helices, parallel and anti-parallel beta sheets) as a function of temperature and environment.
A broadly interdisciplinary collaboration has been established with the Department of Ophthalmology in the Stanford School of Medicine. We have designed and synthesized a fully interpenetrating network of two different hydrogel materials that have properties consistent with application as a substitute for the human cornea: high water swellability up to 85%,tensile strength comparable to the cornea, high glucose permeability comparable to the cornea, and sufficient tear strength to permit suturing. We have developed a technique for surface modification with adhesion peptides that allows binding of collagen and subsequent growth of epithelial cells. Broad questions on the relationships among molecular structure, processing protocol, and biomedical device application are being pursued. -
Eliana Frank
Division Clinical Research Manager, Pediatrics - Endocrinology
Current Role at StanfordDivision Clinical Research Manager - Pediatric Endocrinology
-
Matthew Frank
Assistant Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Matthew Frank, MD, PhD, is an Assistant Professor of Medicine in the Division of Blood and Marrow Transplantation and Cellular Therapy at Stanford University. Dr. Frank predominantly cares for patients with high-risk lymphoma and other blood cancers. He is a lead investigator of clinical trials evaluating the safety and effectiveness of cancer treatments called chimeric antigen receptor (CAR ) T therapy for patients with lymphomas and leukemias. Dr. Frank’s research focuses on developing methods to identify patients who are at high risk for relapse or developing side-effects after receiving CAR T therapy and to understand why these relapses and side-effects occur.
-
Michael Frank
Benjamin Scott Crocker Professor of Human Biology and Professor, by courtesy, of Linguistics
Current Research and Scholarly InterestsHow do we learn to communicate using language? I study children's language learning and how it interacts with their developing understanding of the social world. I use behavioral experiments, computational tools, and novel measurement methods like large-scale web-based studies, eye-tracking, and head-mounted cameras.
-
Lorry Frankel
Professor of Pediatrics (Critical Care) at the Lucile Salter Packard Children's Hospital at Stanford, Emeritus
Current Research and Scholarly Interests1) Collaborative efforts with Dale Umetsu and Dave Lewis in evaluating alveolar macrophage response to antigen. We try to examine cytokine activation and inhibition. I perform bronchoalveolar lavage in these patients in order to obtain alveolar macrophages which we culture, stimulate and study.
2) Evaluate outcomes for patients admitted to the Pediatric Intensive Care Unit from the EMS services for trauma and other life-threatening events. -
Brian James Franklin
Affiliate, Department Funds
Resident in Emergency MedicineCurrent Research and Scholarly InterestsHospital capacity, patient flow, emergency department boarding/hospital crowding
-
Jennifer Frankovich
Clinical Professor, Pediatrics - Rheumatology
Current Research and Scholarly InterestsMy primary interest and role at Stanford is to evaluate and treat children with both systemic and organ specific autoimmune disease. In October of 2012, we started a multidisciplinary clinic dedicated to treating patients with PANS (Pediatric Acute-onset Neuropsychiatric Syndromes). I am currently the clinical and research director for the PANS program.
-
Hunter Fraser
Professor of Biology
Current Research and Scholarly InterestsWe study the evolution of complex traits by developing new experimental and computational methods.
Our work brings together quantitative genetics, genomics, epigenetics, and evolutionary biology to achieve a deeper understanding of how genetic variation shapes the phenotypic diversity of life. Our main focus is on the evolution of gene expression, which is the primary fuel for natural selection. Our long-term goal is to be able to introduce complex traits into new species via genome editing.
